Stage-specific modulation of multinucleation, fusion, and resorption by the long non-coding RNA DLEU1 and miR-16 in

Sara Reis Moura1,2,3, Ana Beatriz Sousa1,2,3, Jacob Bastholm Olesen4,5,6

  • 1i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

Cell Death & Disease
|October 10, 2024
PubMed

Insights

Novel non-coding RNAs, DLEU1 and miR-16, show potential for treating bone diseases by modulating osteoclast activity and bone resorption. These molecules offer new therapeutic targets for skeletal conditions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Osteoclasts are crucial for bone resorption, and their modulation is key in preventing bone diseases.
  • There is a need for new anti-resorption agents beyond current therapies.

Purpose of the Study:

  • To investigate non-coding RNAs (ncRNAs) DLEU1 and miR-16 as novel therapeutic targets for modulating osteoclast function.
  • To elucidate the distinct mechanisms by which DLEU1 and miR-16 affect osteoclastogenesis and bone resorption.

Main Methods:

  • Investigated the role of DLEU1 and miR-16 in osteoclast differentiation and fusion using cell culture models.
  • Analyzed the impact of DLEU1 and miR-16 on osteoclast formation, nuclearity, and bone resorption.
  • Utilized techniques to assess cell fusion, monocyte differentiation, and resorption pit formation.

Main Results:

  • DLEU1 silencing impaired osteoclast fusion by affecting the phagocytic cup modality and reducing fusion events.
  • miR-16 influenced monocyte differentiation, impacting osteoclast formation but not nuclear number at early stages.
  • Both ncRNAs affected resorption speed in pit-forming osteoclasts; increased miR-16 also reduced trench formation and resorbed area.

Conclusions:

  • DLEU1 and miR-16 represent promising ncRNA targets for developing novel therapies against bone-related diseases.
  • These ncRNAs offer distinct pathways to control osteoclastogenesis and bone resorption, providing versatile therapeutic strategies.
  • Targeting DLEU1 and miR-16 could ameliorate bone destruction in various skeletal pathologies.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K